Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer

Saved in:
Bibliographic Details
Published in:Cancer Medicine
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870116412725395456
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Medicine
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:100113
institution FRELIP
journal_source_facet Cancer Medicine
last_indexed 2026-07-08T03:39:51.104Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_alt Asociación del CPS de PD-L1 con la eficacia de nivolumab de primera línea más quimioterapia para el cáncer gástrico avanzado o recurrente irresecable
Association du CPS PD-L1 avec l'efficacité du nivolumab de première ligne plus chimiothérapie pour le cancer gastrique avancé ou récurrent non résécable
Associação do CPS de PD-L1 com a eficácia de nivolumabe de primeira linha mais quimioterapia para câncer gástrico avançado irressecável ou recorrente
title_auth Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_es_txt Asociación del CPS de PD-L1 con la eficacia de nivolumab de primera línea más quimioterapia para el cáncer gástrico avanzado o recurrente irresecable
title_fr_txt Association du CPS PD-L1 avec l'efficacité du nivolumab de première ligne plus chimiothérapie pour le cancer gastrique avancé ou récurrent non résécable
title_full Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_fullStr Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_full_unstemmed Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_pt_txt Associação do CPS de PD-L1 com a eficácia de nivolumabe de primeira linha mais quimioterapia para câncer gástrico avançado irressecável ou recorrente
title_short Association of the PD‐L1 CPS With the Efficacy of First‐Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer
title_sort association of the pd‐l1 cps with the efficacy of first‐line nivolumab plus chemotherapy for unresectable advanced or recurrent gastric cancer
topic Oncology
General
Oncology
url https://onlinelibrary.wiley.com/doi/10.1002/cam4.72095?af=R